FRONTLINE® becomes Brand of the Year 2021-22 FRONTLINE® becomes Brand of the Year 2021-22 FRONTLINE® becomes Brand of the Year 2021-2022 in World Branding Awards
A tool to aid in the prevention of African swine fever A tool to aid in the prevention of African swine fever ASF COMBAT is an online management and biosecurity assessment tool aimed at reducing the African swine fever introduction risk level.
Distributing medicine globally with pharmaceutical logistics Distributing medicine globally with pharmaceutical logistics From Germany to Australia, here’s what it takes from operations and logistics to ensure patients get their medicine on time, every time.
Lead with Pride – for the Benefit of All. Lead with Pride – for the Benefit of All. How Inclusive Leadership advocates for Acceptance and creating a Sense of Belonging
Our Venture Fund on the search for groundbreaking trends Our Venture Fund on the search for groundbreaking trends The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
2024 half year results innovation progress 2024 half year results innovation progress First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
The impact of carbon reduction projects The impact of carbon reduction projects Boehringer Ingelheim voluntarily contributes to carbon reduction projects that benefit sustainable development.
The status of schizophrenia care The status of schizophrenia care A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
Boehringer Ingelheim half-year results 2023 Boehringer Ingelheim half-year results 2023 First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
Stroke symptoms Stroke symptoms The Angels initiative, stroke symptoms, giving life a chance, optimizing stroke care
Professor Richeldi treatment initiation Professor Richeldi treatment initiation Leading pulmonologist Professor Richeldi discusses why early initiation of treatment in Idiopathic Pulmonary Fibrosis is important.
Taking Cancer On: The Podcast Taking Cancer On: The Podcast From early stage discovery to clinical trials and approval, we’re Taking Cancer On.
Cat vaccination 10 things you should know Cat vaccination 10 things you should know Find out how you can keep your feline companion happy and healthy.
New indications NexGard, NexGard SPECTRA and Broadline New indications NexGard, NexGard SPECTRA and Broadline New therapeutic indications for NexGard®, NexGard SPECTRA® and Broadline® approved by EMA
Pulmonary Fibrosis: Early discovery makes all the difference Pulmonary Fibrosis: Early discovery makes all the difference Video taking a deep dive into pulmonary fibrosis. Visit an underwater world that brings to life the physical change PF has on the lungs.
Heart Diseases in humans and animals Heart Diseases in humans and animals Humans and animals are more alike than different. Having a heart disease can affect us similarly, and the way to prevent it can work for all as well.
FDA-Fast-Track-chronic-kidney-disease FDA-Fast-Track-chronic-kidney-disease FDA grants Fast Track designation for the treatment of chronic kidney disease, underscoring urgent need for new treatments for people living with the condition
Three challenges shape future antiparasitic treatment Three challenges shape future antiparasitic treatment The three key challenges that will shape the future of antiparasitic treatment
Grass Roots Grass Roots Grass Roots Innovation: Championing the Next Generation of Life-Science Innovators
Our partners university of georgia Our partners university of georgia We're partnering with the University of Georgia to address unmet needs and find solutions to some of the biggest challenges in animal health.
Future of Diabetes Future of Diabetes This video highlights the evolution of type 2 diabetes management
Boehringer founding sponsor of CKM Health Initiative Boehringer founding sponsor of CKM Health Initiative Boehringer Ingelheim founding sponsor of AHA's Cardiovascular-Kidney-Metabolic Health Initiative